Innosys, a specialized orthopedic implant research and manufacturing company led by CEO Ju Mi Chung, recently conducted educational sessions for visiting Mexican orthopedic specialists. The sessions showcased posterior spinal fusion techniques using the company’s spinal fixation device, ‘ANAX 5.5 Deformity System’ (hereafter referred to as ANAX 5.5), as announced on the 17th.
The educational program was overseen by Professor Chang Ju Hwang from Asan Medical Center and Professor Ho Joong Kim from Seoul National University Bundang Hospital. Participants observed posterior fusion procedures utilizing ANAX 5.5 to correct spinal curvatures in two patients suffering from scoliosis and kyphosis. Scoliosis, characterized by abnormal curvature and misalignment of the spine, requires prompt treatment to prevent the progression of spinal deformity and associated complications. The Mexican medical professionals acknowledged the superiority of ANAX 5.5 in posterior fusion procedures and expressed high interest in its potential application in their local medical settings.
ANAX 5.5 is a spinal fixation device designed to correct spinal deformities and prevent further abnormalities. It is indicated for conditions such as spondylolisthesis, spinal stenosis, and scoliosis. The device allows for screw angle adjustments up to 65 degrees and enables more precise intraoperative positioning, enhancing surgical flexibility and reducing surgeon fatigue. The dual-threaded screw design minimizes insertion resistance, reducing the force and fatigue associated with surgical instrument use, thereby facilitating smoother procedures.
ANAX 5.5 has been introduced in 14 countries, including Mexico and other key South American nations such as Chile, Colombia, and Venezuela, as well as Southeast Asian countries like Vietnam, Thailand, and Indonesia. It has garnered high acclaim in the global spinal correction field. Innosys plans to strengthen its foothold in the South American market by expanding into Peru, Ecuador, Nicaragua, Argentina, Puerto Rico, and Bolivia.
Driven by technological advancements and improved access to medical services, the Latin American market for spinal correction medical devices is projected to grow at an annual rate of 9.2%. Mexico, in particular, is expected to see an increase in various spinal disorders due to its aging population trend. Consequently, Innosys’s ANAX 5.5 is anticipated to play a crucial role in treating orthopedic conditions across Mexico and the broader Latin American region.
Dr. Arturo Rodríguez Montalvo, who observed the educational sessions, noted: “It was incredibly meaningful to witness Korea’s premier scoliosis surgical techniques. I’m eager to apply these new technologies to benefit more patients in my home country.” He added, “Visiting the Innosys factory and directly observing the manufacturing process of these high-quality products has significantly increased my confidence in their safety and efficacy.”
“I was impressed by the high medical standards, extensive treatment experience, systematic diagnostic processes, and close collaboration among medical staff at Asan Medical Center and Seoul National University Bundang Hospital. This educational opportunity not only showcased Korea’s excellent medical technology but also left me with a positive impression of the country itself,” remarked Dr. Fabián Catarino López.
“We anticipate that the application of high-complexity surgical techniques using Innosys products in Mexico, a leading country in the Latin American medical device market, will contribute to improving the quality of life for patients in the region.” She added, “We will continue our efforts to disseminate Korea’s advanced medical technologies in the global market and ensure that more patients can benefit from these cutting-edge medical innovations,” stated Ju Mi Chung, CEO of Innosys.
